Literature DB >> 31750813

Pseudomonas aeruginosa and microbial keratitis.

Yasmin Hilliam1, Stephen Kaye2, Craig Winstanley1.   

Abstract

Pseudomonas aeruginosa, a versatile Gram-negative pathogen that can cause a wide range of infections, is the most common causative agent in cases of bacterial keratitis associated with contact-lens use. Corneal infections with P. aeruginosa often have poor clinical outcomes and can result in long and costly treatments. During the infection process, the pathogen exploits its large genome, encoding complex regulatory networks and a wide range of virulence factors, including motility and the secretion of various proteases and toxins. Although antibiotic resistance levels in the UK are low, higher levels have been seen in some other countries. In the face of increasing antibiotic resistance, alternative therapeutic approaches such as antivirulence strategies and phage therapy are being developed. There is increasing evidence to suggest that keratitis infections are associated with a phylogenetic subgroup of P. aeruginosa isolates carrying the gene encoding the potent cytotoxin exotoxin U, one of two mutually exclusive exotoxins secreted via the type III secretion system. The mechanisms behind this association are unclear, but understanding the genetic differences that predispose P. aeruginosa to cause corneal infections may allow for the development of targeted and more effective future treatments to reduce the morbidity of P. aeruginosa keratitis. In order to minimize the risk of severe P. aeruginosa eye infections, a wide range of contact-lens disinfection solutions are available. Constant exposure to biocides at a range of concentrations, from sub-inhibitory to inhibitory, could contribute to the development of resistance to both antibiotics and disinfectants.

Entities:  

Keywords:  Pseudomonas aeruginosa; disinfectants; keratitis; virulence

Mesh:

Substances:

Year:  2020        PMID: 31750813     DOI: 10.1099/jmm.0.001110

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  16 in total

Review 1.  A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens: computational tools and recent advancements.

Authors:  P Priyamvada; Reetika Debroy; Anand Anbarasu; Sudha Ramaiah
Journal:  World J Microbiol Biotechnol       Date:  2022-07-05       Impact factor: 3.312

2.  Cationic polymer contributes to broaden the spectrum of vancomycin activity achieving eradication of Pseudomonas aeruginosa.

Authors:  Melisa B Corti; Luciana P Campagno; Verónica L Romero; Silvina Gutierrez; Fabiana L Alovero
Journal:  Arch Microbiol       Date:  2022-07-20       Impact factor: 2.667

3.  Molecular characterization and antibiogram of the carbapenemase gene variants in clinical strains of Pseudomonas aeruginosa.

Authors:  Hasan Ejaz
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

4.  Povidone Iodine 0.66% to Fight Pseudomonas aeruginosa in Contact Lens Wearer: A Case Report.

Authors:  Stefano Castelnuovo
Journal:  Case Rep Ophthalmol       Date:  2022-05-31

5.  Melatonin inhibits Gram-negative pathogens by targeting citrate synthase.

Authors:  Fang He; Yuan Liu; Pan Li; Xiaoyan Wu; Yaoyao Xia; Dong Zhang; Nengzhang Li; Yuanyi Peng; Guoqiang Zhu; Rüdiger Hardeland; Russel J Reiter; Wenkai Ren
Journal:  Sci China Life Sci       Date:  2022-01-05       Impact factor: 10.372

6.  Random Peptide Mixtures as Safe and Effective Antimicrobials against Pseudomonas aeruginosa and MRSA in Mouse Models of Bacteremia and Pneumonia.

Authors:  Richard C Bennett; Myung Whan Oh; Shanny Hsuan Kuo; Yael Belo; Bar Maron; Einav Malach; Jingjun Lin; Zvi Hayouka; Gee W Lau
Journal:  ACS Infect Dis       Date:  2021-03-02       Impact factor: 5.084

Review 7.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

8.  Treatment of Corneal Infections Utilizing an Ocular Wound Chamber.

Authors:  Jennifer S McDaniel; Laura L F Scott; Jennifer Rebeles; Gregory T Bramblett; Elof Eriksson; Anthony J Johnson; Gina L Griffith
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

9.  Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa.

Authors:  Stephnie M Kennedy; Pallavi Deshpande; Andrew G Gallagher; Malcolm J Horsburgh; Heather E Allison; Stephen B Kaye; Donald A Wellings; Rachel L Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

10.  Clearance of Gram-Negative Bacterial Pathogens from the Ocular Surface by Predatory Bacteria.

Authors:  Eric G Romanowski; Shilpi Gupta; Androulla Pericleous; Daniel E Kadouri; Robert M Q Shanks
Journal:  Antibiotics (Basel)       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.